Samuel J. Cler, MD

Samuel J. Cler, MD

MD: Washington University in St. Louis School of Medicine

Hometown: Bloomington, IL

Personal Statement: WashU Otolaryngology offers everything I could want in a training program – a tremendous operative experience, strong representation of all sub-specialties, and research support that is second to none. For me, however, the most important part is the people. The residents and faculty are very welcoming, which makes the program feel like a family.


Undergraduate: University of Illinois at Urbana Champaign, 2019

Medical School: Washington University in St. Louis School of Medicine, 2023


  • Acoustic Neuroma Association Research Grant Recipient, 2022
  • WashU Class of ’54 Scholarship, 2019-2023


  1. Lauzier DC, Huguenard AL, Srienc AI, Cler SJ, Osbun JW, Chatterjee AR, Vellimana AK, Kansagra AP, Derdeyn CP, Cross DT, Moran CJ. A review of technological innovations leading to modern endovascular brain aneurysm treatment. Front Neurol. 2023 Apr 11;14:1156887. doi: 10.3389/fneur.2023.1156887. PMID: 37114225; PMCID: PMC10126349.
  2. Lauzier DC, Srienc AI, Cler SJ, Osbun JW. Letter to the Editor. Ruptured AVMs in children. J Neurosurg Pediatr. 2023 Jan 27;31(4):389-390. doi: 10.3171/2022.12.PEDS22529. PMID: 36708536.
  3. Lauzier DC, Cler SJ, Huguenard AL, Chatterjee AR, Osbun JW. Letter to the Editor. Delayed recurrence following radiographic cure of pediatric AVMs. J Neurosurg Pediatr. 2022 Nov 11;31(2):192-193. doi: 10.3171/2022.9.PEDS22395. PMID: 36599083.
  4. Lauzier DC, Cler SJ, Osbun JW, Chatterjee AR, Moran CJ, Kansagra AP. Management of In-Stent Stenosis with Dual Antiplatelet Therapy Following Pipeline Embolization of Intracranial Aneurysms. World Neurosurg. 2022 Nov;167:e303-e309. doi: 10.1016/j.wneu.2022.08.002. Epub 2022 Aug 7. PMID: 35948233.
  5. Lauzier DC, Cler SJ, Vellimana AK, Osbun JW, Chatterjee AR, Derdeyn CP, Cross DT, Moran CJ, Kansagra AP. Evolution of Elective Intracranial Aneurysm Treatment. World Neurosurg. 2022 Dec;168:309-310. doi: 10.1016/j.wneu.2022.08.133. Epub 2022 Aug 30. PMID: 36055621.
  6. Cler SJ, Lauzier DC, Kansagra AP, Letter: Safety and Efficacy of the Off-Label Use of Pipeline Embolization Device Based on the 2018 Food and Drug Administration-Approved Indications for Intracranial Aneurysms: A Single-Center Retrospective Cohort Study. Neurosurgery, Accepted, Ahead of Print
  7. Cler SJ, Lauzier DC, Chatterjee AR, Osbun JW, Moran CJ, Kansagra AP. Timeline of Occlusion for Intracranial Aneurysms Treated with the Pipeline Embolization Device [published online ahead of print, 2022 Aug 2]. World Neurosurg. 2022;S1878-8750(22)01032-4. doi:10.1016/j.wneu.2022.07.084
  8. Lauzier DC, Cler SJ, Chatterjee AR, Osbun JW, Moran CJ, Kansagra AP. Retreatment of previously flow diverted intracranial aneurysms with the pipeline embolization device. Interv Neuroradiol. 2022 Jun 26:15910199221111284. doi: 10.1177/15910199221111284. Epub ahead of print. PMID: 35758311.
  9. Cler SJ, Schneider J. The Orbital Apex Cell as a Landmark for Endoscopic Navigation to the Sphenoid Sinus [published online ahead of print, 2022 Jun 4]. Ear Nose Throat J. 2022;1455613221106222. doi:10.1177/01455613221106222
  10. Cler SJ, Dunn GP, Zipfel GJ, Dacey RG, Chicoine MR. A Low Subfrontal Dural Opening for Operative Management of Anterior Skull Base Lesions. J Neurol Surg B Skull Base. 2022(EFirst).
  11. Cler SJ, Skidmore A, Yahanda AT, et al. Genetic and histopathological associations with outcome in pediatric pilocytic astrocytoma [published online ahead of print, 2022 Feb 11]. J Neurosurg Pediatr. 2022;1-9. doi:10.3171/2021.9.PEDS21405
  12. Cler SJ, Lauzier DC, Chatterjee AR, Osbun JW, Moran CJ, Kansagra AP. Comparative study of on-label versus off-label treatment of intracranial aneurysms with the Pipeline embolization device [published online ahead of print, 2022 Jan 28]. J Neurosurg. 2022;1-6. doi:10.3171/2021.11.JNS212481
  13. Brossier NM, Strahle JM, Cler SJ, Wallendorf M, Gutmann DH. Children with supratentorial midline pilocytic astrocytomas exhibit multiple progressions and acquisition of neurologic deficits over time. Neurooncol Adv. 2021;4(1):vdab187. Published 2021 Dec 27. doi:10.1093/noajnl/vdab187
  14. Lauzier DC, Cler SJ, Kansagra AP. Examining the Value of Neurointerventional Follow-up. World Neurosurg. 2021 Nov;155:191-192. doi: 10.1016/j.wneu.2021.08.059. PMID: 34724733.
  15. Lauzier DC, Cler SJ, Chatterjee AR, Osbun JW, Moran CJ, Kansagra AP. The value of long-term angiographic follow-up following Pipeline embolization of intracranial aneurysms. J Neurointerv Surg. 2021 Jul 1:neurintsurg-2021-017745. doi: 10.1136/neurintsurg-2021-017745. Epub ahead of print. PMID: 34210838.
  16. Cler SJ, Sharifai N, Baker B, et al. IgG4-Related Disease of the Skull and Skull Base, A Systematic Review and Report of Two Cases: Review of Skull Base IgG4-Related Disease [published online ahead of print, 2021 Mar 18]. World Neurosurg. 2021; S1878-8750(21)00422-8. doi:10.1016/j.wneu.2021.03.054
  17. Shahoei SH, Kim YC, Cler SJ, et al. Small Heterodimer Partner Regulates Dichotomous T Cell Expansion by Macrophages. Endocrinology. 2019;160(7):1573-1589. doi:10.1210/en.2019-00025